FDA PEPTIDE DEBATE COULD RESHAPE WELLNESS INDUSTRY

Photo Credit: Getty Images
A little-known advisory committee within the United States Food and Drug Administration has become the focus of intense attention as regulators consider whether several controversial peptide compounds should become more accessible through licensed compounding pharmacies.







